Genmab News

Genmab News

To comply with applicable regulation in Denmark, product-related media releases are removed from our website within three weeks of publication. They are available upon request. Please contact us here.

 

Jan 24, 2023 at 8:01 PM CET
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Download
Jan 24, 2023 at 12:28 PM CET
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022
Download
Jan 19, 2023 at 5:01 PM CET
Correction to Company Announcement No. 1 of January 3, 2023
Download
Jan 3, 2023 at 6:32 PM CET
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Download
Jan 2, 2023 at 1:57 PM CET
Genmab to Present at the 41st Annual J.P. Morgan Healthcare Conference
Download

  • Who we are

    Read about Genmab's purpose, core values and key accomplishments

    Learn more

  • Turning insights into medicine

    See the results of innovation that is rooted in science

    Explore the pipeline

  • Innovation for the future

    We are developing next-generation technologies

    See our technologies

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.

Continue

Back